Bristol Myers' Experimental CAR-T Therapy Shows Promise in Multiple Myeloma

Bristol Myers Squibb says its experimental CAR-T therapy arlo-cel produced a high response rate in patients with advanced multiple myeloma who had exh…

Continue in Briflio to read, react, comment, and share.